Trial Profile
Interventional, Randomised, Double-blind, Placebo-controlled, Active Comparator, Four-way Crossover Electroencephalography Study Investigating the Effects of Vortioxetine (Lu AA21004) in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary) ; Escitalopram
- Indications Anxiety disorders; Generalised anxiety disorder; Major depressive disorder
- Focus Pharmacodynamics
- Sponsors Lundbeck A/S
- 22 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Mar 2014 New trial record